Advertisement

Excimer Laser Trabeculostomy (ELT): An Effective MIGS Procedure for Open-Angle Glaucoma

  • Michael S. Berlin
  • Marc Töteberg-Harms
  • Edward Kim
  • Iris Vuong
  • Ulrich Giers
Chapter

Abstract

Excimer laser trabeculostomy (ELT) is a safe and effective micro-invasive glaucoma surgery (MIGS) procedure for the reduction of both intraocular pressure (IOP) and pressure-lowering medications in patients with open-angle glaucoma. Significantly less invasive relative to most current glaucoma surgical procedures, ELT preserves the integrity of the meshwork and Schlemm's canal, restoring natural outflow without the creation of blebs or the implantation of foreign bodies. Compared to filtering procedures such as trabeculectomy, ELT not only reduces the number of postoperative visits required to assure adequacy and stability but also eliminates most postoperative risks in both short and long terms. By minimizing the healing responses induced by tissue trauma and thermal effects inherent to other MIGS procedures, ELT enables a consistent lowering of IOP on a long-term basis. Furthermore, due to the minimal tissue trauma associated with tissue trauma associated with ultra-violet (UV) tissue photoablation, only a few small channels into Schlemm's canal have proven adequate to control the IOP. In addition, ELT can be readily performed concurrent with lensectomy with significant long-term pressure-lowering effects far greater than lensectomy alone, allowing the physician to address two pathologies in one surgical intervention.

Keywords

Anterior Chamber Trabecular Meshwork Selective Laser Trabeculoplasty Antiglaucoma Medication Glaucoma Drainage Device 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Saheb H, Ahmed II. Micro-invasive glaucoma surgery: current perspectives and future directions. Curr Opin Ophthalmol. 2012;23(2):96–104. doi: 10.1097/ICU.0b013e32834ff1e7. Review. PubMed PMID: 22249233.
  2. 2.
    Krasnov MM. Laseropuncture of anterior chamber angle in glaucoma. Am J Ophthalmol. 1973;75:674.PubMedGoogle Scholar
  3. 3.
    Hager H. Besondere mikrochirurgische Eingriffe. 2. Teil. Erste Erfahrungen mit dem Argon-Laser-Geraet 800. Klin Monatsbl Augenheilkd. 1973;162:437–50.PubMedGoogle Scholar
  4. 4.
    Van der Zypen E, Fankhauser F, Bebie H, Marshall J. Changes in the ultrastructure of the iris after irradiation with intense light. A study of long-term effects after irradiation with argon ion. Nd:YAG and Q-switched ruby laser. Adv Ophthalmol. 1979;39:59–180.PubMedGoogle Scholar
  5. 5.
    Beckman H, Kinoshita A, Rota AN, et al. Transscleral ruby laser irradiation of the ciliary body in the treatment of intractable glaucoma. Trans Am Acad Ophthalmol Otolaryngol. 1973;46:423.Google Scholar
  6. 6.
    Beckman H, Sugar HS. Neodymium laser cyclocoagulation. Arch Ophthalmol. 1973;90:27.PubMedCrossRefGoogle Scholar
  7. 7.
    Wise JB. Long-term control of adult open angle glaucoma by argon laser treatment. Ophthalmology. 1981;8:197.CrossRefGoogle Scholar
  8. 8.
    Glaucoma Laser Trial Research Group. The Glaucoma Laser Trial (GLT) and glaucoma laser trials follow-up study. 7. Results. Am J Ophthalmol. 1995;120:718.Google Scholar
  9. 9.
    Odberg T, Sandvik L. The medium- and long-term efficacy of primary argon laser trabeculoplasty in avoiding topical medication in open-angle glaucoma. Acta Ophthalmol Scand. 1999;77:176–81.PubMedCrossRefGoogle Scholar
  10. 10.
    Heijl A, et al. Reduction of IOP and glaucoma progression: results from the early manifest glaucoma trial. Arch Ophthalmol. 2002;120:1268.PubMedCrossRefGoogle Scholar
  11. 11.
    Shingleton BJ, et al. Long-term efficacy of argon laser trabeculoplasty: a 10-year follow-up study. Ophthalmology. 1998;100:1324.CrossRefGoogle Scholar
  12. 12.
    Damji K, et al. Selective laser trabeculoplasty vs. argon laser trabeculoplasty: a prospective clinical trial. Br J Ophthalmol. 1995;83:718.CrossRefGoogle Scholar
  13. 13.
    Latina MA, Gulati V. Selective laser trabeculoplasty: stimulating the meshwork to mend its ways. Int Ophthalmol Clin. 2004;44:93.PubMedCrossRefGoogle Scholar
  14. 14.
    Jacobi PC, Dietlein TS, Krieglstein GK. Prospective study of ab externo erbium:YAG laser sclerostomy in humans. Am J Ophthalmol. 1997;123:478.PubMedGoogle Scholar
  15. 15.
    Iwach AG, et al. Update on the subconjunctival THC:YAG (holmium) laser sclerostomy ab externo clinical trial: a 4-year report. Ophthalmic Surg Lasers. 1996;27:823.PubMedGoogle Scholar
  16. 16.
    Latina MA, Park C. Selective targeting of trabecular meshwork cells: in vitro studies of pulsed and CW interactions. Exp Eye Res. 1995;60:359.PubMedCrossRefGoogle Scholar
  17. 17.
    Maguen E, Martinez M, Grundfest W, Papaioannou T, Berlin M. Excimer laser ablation of the human lens at 308 nm with a fiber delivery system. In: XXVI world congress of the International College of Surgeons, Milan, 3–9 July 1988.Google Scholar
  18. 18.
    Tripathy RC. Ultrastructure of Schlemm’s canal in relation to aqueous outflow. Exp Eye Res. 1968;7:335–41.CrossRefGoogle Scholar
  19. 19.
    Holmberg A. Schlemm’s canal and the trabecular meshwork. An electron microscopic study of the normal structure in man and monkey (Cercopithecus aethiops). Doc Ophthalmol. 1965;19:339.CrossRefGoogle Scholar
  20. 20.
    Berlin MS, Rajacich G, Duffy M. Excimer laser photoablation in glaucoma filtering surgery. Am J Ophthalmol. 1987;103:713–714.3.PubMedGoogle Scholar
  21. 21.
    Huang S, Yu M, Feng G, Zhang P, Qiu C. Histopathological study of trabeculum after excimer laser trabeculectomy ab interno. Yan Ke Xue Bao. 2001;17(1):11–5.PubMedGoogle Scholar
  22. 22.
    Vogel M, Lauritzen K. Selective excimer laser ablation of the trabecular meshwork. Clinical results. Ophthalmologe. 1997;94(9):665–7.PubMedCrossRefGoogle Scholar
  23. 23.
    Jahn R, et al. Macroscopic and microscopic findings after excimer laser treatment of different tissue. J Clin Laser Med Surg. 1992;10:413.PubMedGoogle Scholar
  24. 24.
    Neuhann T, Scharrer A, Haefliger E. Excimer laser trabecular ablation ab interno (ELT) in the treatment of chronic open-angle glaucoma, a pilot study. Ophthalmochirugie. 2001;13:3.Google Scholar
  25. 25.
    Laurtizen K, Vogel M. Trabecular meshwork ablation with excimer laser – a new concept of therapy for glaucoma patients. Invest Ophthalmol Vis Sci. 1997;38:826.Google Scholar
  26. 26.
    Walker R, Specht H. Theoretical and physical aspects of excimer laser trabeculotomy (ELT) ab interno with the AIDA laser operating at a wavelength of 308 nm. Biomed Tech (Berl). 2002;47:106.CrossRefGoogle Scholar
  27. 27.
    Kaufmann R, Hibst R. Pulsed Er:YAG and 308 nm UV excimer laser: an in vitro and in vivo study of skin-ablative effects. Laser Surg Med. 1989;9:132.CrossRefGoogle Scholar
  28. 28.
    Berlin MS. Excimer laser applications in glaucoma surgery. Ophthalmol Clin North Am. 1988;1:255.Google Scholar
  29. 29.
    Berlin MS, et al. Excimer laser photoablation in glaucoma filtering surgery. Am J Ophthalmol. 1984;103:713.Google Scholar
  30. 30.
    Pache M, et al. Laser surgery for glaucoma: excimer-laser trabeculotomy. Klin Monbl Augenheilkd. 2006;223(4):303–7.PubMedCrossRefGoogle Scholar
  31. 31.
    Töteberg-Harms M, Hanson JV, Funk J. Cataract surgery combined with excimer laser trabeculotomy to lower intraocular pressure: effectiveness dependent on preoperative IOP. BMC Ophthalmol. 2013 Jun 24;13:24. doi: 10.1186/1471-2415-13-24. PubMed PMID: 23799932; PubMed Central PMCID: PMC3724507.
  32. 32.
    Wilmsmeyer S, et al. Excimer laser trabeculotomy: a new, minimally invasive procedure for patients with glaucoma. Graefes Arch Clin Exp Ophthalmol. 2006;244:670–6.PubMedCrossRefGoogle Scholar
  33. 33.
    Babighian S, et al. Efficacy and safety of ab interno excimer laser trabeculotomy in primary open-angle glaucoma: two years of follow-up. Ophthalmologica. 2006;220:285–90.PubMedCrossRefGoogle Scholar
  34. 34.
    Töteberg-Harms M, et al. One-year results after combined cataract surgery and excimer laser trabeculotomy for elevated intraocular pressure. Ophthalmologe. 2011;108(8):733–8.PubMedCrossRefGoogle Scholar
  35. 35.
    Berlin MS, Kleinberg L, Stodtmeister R, Spitz J, Giers U. The IOP lowering efficacy of excimer-laser-trabeculostomy in open angle glaucoma patients remains consistent over 5 years. Poster session presented at: 23rd annual meeting of the American Glaucoma Society, San Francisco, 1–3 Mar 2013.Google Scholar
  36. 36.
    Stodtmeister R, Kleinberg L, Berlin M, Pillunat L, Giers U. Excimer laser trabeculostomy: 5-year follow-up. Abstract submitted for: the 111th congress of the German Association of Ophthalmologists, Berlin, 19–22 Sept 2013.Google Scholar
  37. 37.
    Jampel HD, Musch DC, Gillespie BW, et al., the CIGTS Study Group. Perioperative complications of trabeculectomy in the Collaborative Initial Glaucoma Treatment Study (CIGTS). Am J Ophthalmol. 2005;140:16–22.Google Scholar

Copyright information

© Springer Science+Business Media New York 2014

Authors and Affiliations

  • Michael S. Berlin
    • 1
  • Marc Töteberg-Harms
    • 2
  • Edward Kim
    • 3
  • Iris Vuong
    • 3
  • Ulrich Giers
    • 4
  1. 1.Glaucoma Institute of Beverly Hills, Jules Stein Eye Institute, UCLALos AngelesUSA
  2. 2.Department of OphthalmologyUniversity Hospital ZurichZurichSwitzerland
  3. 3.Glaucoma Institute of Beverly HillsLos AngelesUSA
  4. 4.Augen-klinik OWL, DetmoldDetmoldGermany

Personalised recommendations